Press release
The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers
Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles” report to its list of offerings.
Since the early 20th century, over 12,000 patents / patent applications have been granted / filed in relation to drug delivery devices that can either be worn on the body (or implanted), by both industry and non-industry players. Presently, innovation in this domain is focused on developing cheaper and more environment friendly drug delivery systems, with provisions to minimize / altogether eliminate the risk of needlestick injuries.
To order this report, featuring [A] a comprehensive MS Excel datasheet and [B] a detailed summary in MS PowerPoint, please visit this link - https://www.rootsanalysis.com/reports/on-body-drug-delivery-devices-intellectual-property-landscape.html
Key Product Highlights
From 2001 onwards, over 9,600 applications, featuring different types of IP documents, have been filed and published across different jurisdictions, worldwide
Although several patents related to on-body injectors have already been granted, the major corpus of published IP literature is patent applications; other prominent documents include search reports, amended patents and limited patents.
Based on frequency of use, we identified close to 20 domain specific terms that can be used for impactful prior art searches
An analysis of the titles of IP documents related to this particular field revealed infusion pumps, patch pumps and implants to be the preferred choice of keywords describing this particular type of innovation. Most of the IP publications captured in the report describe technologies designed to facilitate the infusion (as observed in 2,300+ titles) of pharmacological fluids.
Close to 650 IP publications emerged as the most valuable documents related to innovations described in contemporary patent literature
Taking into consideration multiple relevant parameters, the report includes a competitive benchmarking and valuation analysis, which offers important insights into the various factors influencing the relative value associated with granted patents, patent applications and other IP publications related to on-body (and implantable) drug delivery devices.
The report focuses on 40 key pockets of innovation (in terms of CPC families and symbols); there are also several companies making attempts to identify and address key white spaces
Considering the primary purpose of portable drug delivery solutions, most of the innovation in this field of research is focused on tools / technologies to safely facilitate the transfer of large volumes of fluids into the body. Despite the proven versatility of on-body / implantable therapy injectors, there are multiple unaddressed areas of concern (mostly related to improving drug delivery features) that are gradually being taken up by stakeholders.
To request a sample copy / brochure of this report, please visit this link - https://www.rootsanalysis.com/reports/on-body-drug-delivery-devices-intellectual-property-landscape.html
Key Questions Answered
What are the various types of IP documents that have been published in relation to on-body drug delivery devices?
What are the key search expressions that can be used to effectively lookup technical documents, describing innovations in wearable / implantable drug delivery solutions?
What is the relative valuation of a particular IP document, or set of IP documents, in comparison to others in the IP landscape?
Who are the current owners of the high value patents related to on-body drug delivery technologies?
What are the key areas of innovation and in what direction is the research in this field, likely to evolve in future?
Who are the most prolific patent applicants in the on-body drug delivery devices IP landscape?
The research includes profiles of key IP applicants (listed below) engaged in this domain; each profile features an overview of the company, financial information (if available), and its proprietary IP related trends.
Amgen
Becton Dickinson
Bigfoot Biomedical
Codman & Shurtleff
DCA Design International
Deka Products
Insulet Corporation
Medtronic
Novo Nordisk
Roche (including the contributions of Roche Diagnostics and Roche Diabetes Care)
Sanofi Aventis
Smiths Medical
Tandem Diabetes Care
For additional details, please visit
https://www.rootsanalysis.com/reports/on-body-drug-delivery-devices-intellectual-property-landscape.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Large Volume Wearable Injectors Market (5th Edition), 2020-2030
2. Novel Drug Reconstitution Systems Market: Industry Trends and Global Forecasts, 2021-2030
3. Novel Ocular Drug Delivery Devices Market: Industry Trends and Global Forecast, 2021-2030
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers here
News-ID: 2415090 • Views: …
More Releases from Roots Analysis
Medical Aesthetics Market CAGR To Be Around 9.4% by 2035, Due To The Growing Dem …
According to our latest market report "Medical Aesthetics Market, Till 2035 by Type of Products and / or Devices Offered, Type of Procedure, End-user, Gender, Distribution Channel and Key Geographical Regions: Industry Trends and Global Forecasts", the global medical aesthetics market size is projected to reach USD 102 billion by 2035 from USD 35 billion in 2023, growing at a CAGR of 9.4% in the forecast period 2023-2035.
The increasing…
In Vitro Diagnostics Market Size to Hit USD 190 billion by 2035 | Exclusive Repo …
The In Vitro Diagnostics Market size was valued at USD 108 billion in 2024 and likely to hit over USD 190 billion by 2035, growing at a CAGR of 5.2% during the forecast period 2024 to 2035
In vitro diagnostics (IVD) are the tests conducted on samples retrieved from human body, such as blood, saliva or tissue in order to detect diseases or conditions. Such tests help diagnose, monitor, and manage…
Skincare Market Revenue to Cross USD 405 billion by 2035 | Roots Analysis
According to our latest market report "Skincare Market by Type of Product by Application, Type of Product by Body Part, Distribution Channel, Type of Offline Distribution Channel, Type of Packaging, Product Category, Gender, Type of Ingredient, and Geography: Industry Trends and Global Forecasts, till 2035", the global skincare market size is projected to reach USD 407 billion by 2035 from USD 185 billion in 2024, growing at a CAGR of…
Virtual Biopsy Market CAGR To Reach 14.47% by 2035, Due to Growing Demand for No …
According to our latest market report "Virtual Biopsy Market by Target Therapeutic Area, Type of Cancer Targeted, Type of Imaging Technology, End Users and Geographical Regions: Industry Trends and Global Forecasts, till 2035", the virtual biopsy market size is projected to reach USD 3.02 billion by 2035 from USD 0.78 billion in 2025, growing at a CAGR of 14.47% in the forecast period till 2035.
Biopsy procedure has been considered…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
